TKB#

Related by string. * * Trench TKB# *

Related by context. Frequent words. (Click for all words.) 76 Commences Phase 75 Initiates Phase II 74 Initiates Phase 72 Pivotal Phase III 72 Initiate Phase 71 Completes Enrollment 71 Panzem R 71 Pivotal Phase 71 Receives Orphan Drug Designation 70 Drug Candidate 70 Presents Positive 70 Phase III Clinical Trial 70 Tesetaxel 70 Preclinical Data 70 liposomal formulation 70 Thiarabine 69 phenylalanine ammonia lyase 69 ALN TTR 69 ALN TTR# 69 AEG# 69 Metastatic Melanoma 68 JAK1 68 PEG SN# 68 proteasome inhibitor 68 Clinical Trial Results 68 CORT # 68 Phase Ib II 68 FDA Accepts 68 Monoclonal Antibody 67 EZN 67 MKC# 67 CCX# 67 Voreloxin 67 polymerase inhibitor 67 TELINTRA 67 refractory chronic lymphocytic 67 multi kinase inhibitor 67 IMC #B 67 novel oral tubulin 67 RGB # 67 Pivotal Study 66 anticancer compound 66 novel orally administered 66 Patient Enrollment 66 GRNVAC1 66 TLR9 agonist 66 PEG PAL PEGylated recombinant 66 Small Molecule 66 topical anti infective 66 humanized anti 66 Daclizumab 66 Idera Pharmaceuticals 66 Epidermal Growth Factor Receptor 66 Recombinant Human 66 Bavituximab 66 RNAi Therapeutics 66 MEK inhibitor 66 PSN# [002] 66 Ofatumumab 65 Phase IIa trials 65 Factor VIIa 65 metastatic castration resistant 65 Shigamabs ® 65 II Clinical Trial 65 PEGylated 65 R sorafenib tablets 65 Single Dose 65 phase IIa clinical 65 hypoxia inducible factor 65 Phase IIb trials 65 metastatic hormone refractory 65 Inc. Nasdaq IMGN 65 HCV protease inhibitor 65 polymerase inhibitors 65 PLK1 SNALP 65 phase IIb clinical 65 Perifosine 65 Sym# 65 R bortezomib 65 forodesine 65 Phase III Trial 65 ThermoDox R 65 Cetrorelix 65 metastatic castrate resistant 65 relapsed refractory multiple myeloma 65 Lubiprostone 64 CR# vcMMAE 64 Advancing Drugs 64 Onalta 64 CD# expressing 64 Nanobody 64 Pivotal Trial 64 Phase 2b clinical trials 64 Dapagliflozin 64 Traficet EN 64 TTR amyloidosis 64 NXL# 64 Guanilib 64 targeting CD# 64 immuno inflammatory diseases 64 Pralatrexate

Back to home page